Davis Polk advised J.P. Morgan, Jefferies and Barclays, the joint book-running manager for the offering. Beam Therapeutics Inc. (Nasdaq: BEAM) announced the pricing of its initial…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now